Suma Krishnan, President, R&D, 10% Owner at Krystal Biotech, Inc. (KRYS), sold 50,000 shares at $257.32 ($13.2M) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Seasonal sale ($13.2M) by President, R&D, 10% Owner — this insider has traded KRYS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $257.32 | 407 | $105K | 0.8% |
| 2 | $257.32 | 407 | $105K | 0.8% |
| 3 | $258.54 | 589 | $152K | 1.2% |
| 4 | $258.54 | 589 | $152K | 1.2% |
| 5 | $259.61 | 668 | $173K | 1.3% |
| 6 | $259.61 | 668 |
| $173K |
| 1.3% |
| 7 | $260.37 | 3,667 | $955K | 7.3% |
| 8 | $260.37 | 3,667 | $955K | 7.3% |
| 9 | $261.41 | 2,931 | $766K | 5.8% |
| 10 | $261.41 | 2,931 | $766K | 5.8% |
| 11 | $262.35 | 1,938 | $508K | 3.9% |
| 12 | $262.35 | 1,938 | $508K | 3.9% |
| 13 | $263.58 | 2,248 | $593K | 4.5% |
| 14 | $263.58 | 2,248 | $593K | 4.5% |
| 15 | $264.64 | 4,852 | $1.3M | 9.8% |
| 16 | $264.64 | 4,852 | $1.3M | 9.8% |
| 17 | $265.16 | 6,000 | $1.6M | 12.1% |
| 18 | $265.16 | 6,000 | $1.6M | 12.1% |
| 19 | $266.42 | 1,700 | $453K | 3.4% |
| 20 | $266.42 | 1,700 | $453K | 3.4% |
| Total | $263.21 avg | 50,000 | $13.2M | 100% |
| Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |
| KRYS | SELL | 2025-07-11 | $4.0M | — | Filing → |